Targeted News Service

TIL Therapy Brings New Hope for Patients With Advanced Melanoma
December 12, 2025

PHILADELPHIA, Pennsylvania, Dec. 12 [Category: Health Care] -- The Fox Chase Cancer Center, a part of Temple University Health System, posted the following news:

* * *

TIL Therapy Brings New Hope for Patients With Advanced Melanoma

*

By Marian Auriemma

Tumor-infiltrating lymphocyte therapy (TIL) is a groundbreaking treatment that uses a patient's immune system to fight cancer. Fox Chase, a leading National Cancer Institute-de . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form